[1]
Parkash V,Fadare O,Tornos C,McCluggage WG, Committee Opinion No. 631: Endometrial Intraepithelial Neoplasia. Obstetrics and gynecology. 2015 Oct [PubMed PMID: 26393443]
[2]
Sherman ME, Theories of endometrial carcinogenesis: a multidisciplinary approach. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2000 Mar [PubMed PMID: 10757340]
[3]
van der Meer AC,Hanna LS, Development of endometrioid adenocarcinoma despite Levonorgestrel-releasing intrauterine system: a case report with discussion and review of the RCOG/BSGE Guideline on the Management of Endometrial Hyperplasia. Clinical obesity. 2017 Feb [PubMed PMID: 27984850]
[4]
Furness S,Roberts H,Marjoribanks J,Lethaby A, Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. The Cochrane database of systematic reviews. 2012 Aug 15; [PubMed PMID: 22895916]
[5]
Kaminski P,Bobrowska K,Pietrzak B,Bablok L,Wielgos M, Gynecological issues after organ transplantation. Neuro endocrinology letters. 2008 Dec [PubMed PMID: 19112398]
[6]
Bobrowska K,KamiĆski P,Cyganek A,Pietrzak B,Jabiry-Zieniewicz Z,Durlik M,Paczek L, High rate of endometrial hyperplasia in renal transplanted women. Transplantation proceedings. 2006 Jan-Feb [PubMed PMID: 16504696]
[7]
Niskakoski A,Pasanen A,Porkka N,Eldfors S,Lassus H,Renkonen-Sinisalo L,Kaur S,Mecklin JP,Bützow R,Peltomäki P, Converging endometrial and ovarian tumorigenesis in Lynch syndrome: Shared origin of synchronous carcinomas. Gynecologic oncology. 2018 Jul [PubMed PMID: 29716739]
[8]
Mills AM,Sloan EA,Thomas M,Modesitt SC,Stoler MH,Atkins KA,Moskaluk CA, Clinicopathologic Comparison of Lynch Syndrome-associated and [PubMed PMID: 26523542]
[10]
Reed SD,Newton KM,Clinton WL,Epplein M,Garcia R,Allison K,Voigt LF,Weiss NS, Incidence of endometrial hyperplasia. American journal of obstetrics and gynecology. 2009 Jun; [PubMed PMID: 19393600]
[11]
Lethaby A,Suckling J,Barlow D,Farquhar CM,Jepson RG,Roberts H, Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. The Cochrane database of systematic reviews. 2004; [PubMed PMID: 15266429]
[12]
Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA. 1996 Feb 7; [PubMed PMID: 8569016]
[13]
Anderson GL,Judd HL,Kaunitz AM,Barad DH,Beresford SA,Pettinger M,Liu J,McNeeley SG,Lopez AM, Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA. 2003 Oct 1; [PubMed PMID: 14519708]
[14]
Kurman RJ,Kaminski PF,Norris HJ, The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer. 1985 Jul 15 [PubMed PMID: 4005805]
[15]
Kurman RJ,Norris HJ, Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer. 1982 Jun 15; [PubMed PMID: 7074572]
[16]
Janicek MF,Rosenshein NB, Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia. Gynecologic oncology. 1994 Mar; [PubMed PMID: 8157194]
[17]
Travaglino A,Raffone A,Saccone G,Mollo A,De Placido G,Insabato L,Zullo F, Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria. Histopathology. 2019 Apr; [PubMed PMID: 30347477]
[18]
Trimble CL,Kauderer J,Zaino R,Silverberg S,Lim PC,Burke JJ 2nd,Alberts D,Curtin J, Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006 Feb 15; [PubMed PMID: 16400639]
[19]
Kendall BS,Ronnett BM,Isacson C,Cho KR,Hedrick L,Diener-West M,Kurman RJ, Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. The American journal of surgical pathology. 1998 Aug; [PubMed PMID: 9706982]
[20]
Emons G,Beckmann MW,Schmidt D,Mallmann P, New WHO Classification of Endometrial Hyperplasias. Geburtshilfe und Frauenheilkunde. 2015 Feb; [PubMed PMID: 25797956]
[21]
Mutter GL, Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Gynecologic oncology. 2000 Mar; [PubMed PMID: 10684697]
[22]
Salman MC,Usubutun A,Boynukalin K,Yuce K, Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia. Journal of gynecologic oncology. 2010 Jun; [PubMed PMID: 20613899]
[23]
Kandoth C,Schultz N,Cherniack AD,Akbani R,Liu Y,Shen H,Robertson AG,Pashtan I,Shen R,Benz CC,Yau C,Laird PW,Ding L,Zhang W,Mills GB,Kucherlapati R,Mardis ER,Levine DA, Integrated genomic characterization of endometrial carcinoma. Nature. 2013 May 2; [PubMed PMID: 23636398]
[24]
Saccardi C,Vitagliano A,Marchetti M,Lo Turco A,Tosatto S,Palumbo M,De Lorenzo LS,Vitale SG,Scioscia M,Noventa M, Endometrial Cancer Risk Prediction According to Indication of Diagnostic Hysteroscopy in Post-Menopausal Women. Diagnostics (Basel, Switzerland). 2020 Apr 27 [PubMed PMID: 32349386]
[25]
Tabor A,Watt HC,Wald NJ, Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding. Obstetrics and gynecology. 2002 Apr [PubMed PMID: 12039131]
[26]
Gupta JK,Chien PF,Voit D,Clark TJ,Khan KS, Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta obstetricia et gynecologica Scandinavica. 2002 Sep [PubMed PMID: 12225294]
[27]
Smith-Bindman R,Kerlikowske K,Feldstein VA,Subak L,Scheidler J,Segal M,Brand R,Grady D, Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA. 1998 Nov 4 [PubMed PMID: 9809732]
[28]
Wolfman W,Leyland N,Heywood M,Singh SS,Rittenberg DA,Soucy R,Allaire C,Awadalla A,Best C,Dunn S,Leroux N,Potestio F,Senikas V,Wallace S,Menzies R, Asymptomatic endometrial thickening. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC. 2010 Oct; [PubMed PMID: 21176311]
[29]
ACOG Committee Opinion No. 440: The Role of Transvaginal Ultrasonography in the Evaluation of Postmenopausal Bleeding. Obstetrics and gynecology. 2009 Aug [PubMed PMID: 19623006]
[30]
Suh-Burgmann E,Hung YY,Armstrong MA, Complex atypical endometrial hyperplasia: the risk of unrecognized adenocarcinoma and value of preoperative dilation and curettage. Obstetrics and gynecology. 2009 Sep [PubMed PMID: 19701030]
[31]
Clark TJ,Mann CH,Shah N,Khan KS,Song F,Gupta JK, Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial hyperplasia. Acta obstetricia et gynecologica Scandinavica. 2001 Sep [PubMed PMID: 11531627]
[32]
Ben-Baruch G,Seidman DS,Schiff E,Moran O,Menczer J, Outpatient endometrial sampling with the Pipelle curette. Gynecologic and obstetric investigation. 1994; [PubMed PMID: 8050731]
[33]
Bedner R,Rzepka-Górska I, Hysteroscopy with directed biopsy versus dilatation and curettage for the diagnosis of endometrial hyperplasia and cancer in perimenopausal women. European journal of gynaecological oncology. 2007 [PubMed PMID: 17966221]
[34]
Terakawa N,Kigawa J,Taketani Y,Yoshikawa H,Yajima A,Noda K,Okada H,Kato J,Yakushiji M,Tanizawa O,Fujimoto S,Nozawa S,Takahashi T,Hasumi K,Furuhashi N,Aono T,Sakamoto A,Furusato M, The behavior of endometrial hyperplasia: a prospective study. Endometrial Hyperplasia Study Group. The journal of obstetrics and gynaecology research. 1997 Jun [PubMed PMID: 9255033]
[35]
Gallos ID,Shehmar M,Thangaratinam S,Papapostolou TK,Coomarasamy A,Gupta JK, Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis. American journal of obstetrics and gynecology. 2010 Dec; [PubMed PMID: 20934679]
[36]
Abu Hashim H,Ghayaty E,El Rakhawy M, Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials. American journal of obstetrics and gynecology. 2015 Oct [PubMed PMID: 25797236]
[37]
Gallos ID,Ofinran O,Shehmar M,Coomarasamy A,Gupta JK, Current management of endometrial hyperplasia-a survey of United Kingdom consultant gynaecologists. European journal of obstetrics, gynecology, and reproductive biology. 2011 Oct [PubMed PMID: 21658836]
[38]
Fisher B,Costantino JP,Wickerham DL,Cecchini RS,Cronin WM,Robidoux A,Bevers TB,Kavanah MT,Atkins JN,Margolese RG,Runowicz CD,James JM,Ford LG,Wolmark N, Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. Journal of the National Cancer Institute. 2005 Nov 16 [PubMed PMID: 16288118]
[39]
Lacey JV Jr,Sherman ME,Rush BB,Ronnett BM,Ioffe OB,Duggan MA,Glass AG,Richesson DA,Chatterjee N,Langholz B, Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Feb 10; [PubMed PMID: 20065186]